Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Single-arm Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in Patients With Coronary Artery Stenosis
Conditions
Interventions
Rapamycin target eluting stent
Locations
1
China
Meizhou Peple's Hospital
Meizhou, Guangdong, China
Start Date
February 28, 2022
Primary Completion Date
August 26, 2023
Completion Date
December 31, 2027
Last Updated
November 9, 2023
NCT05681702
NCT07444697
NCT01311323
NCT01524276
NCT06631157
NCT01932411
Lead Sponsor
Shanghai MicroPort Medical (Group) Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions